Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_020137.5(GRIPAP1):c.1669G>A(p.Glu557Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000655 in 1,175,705 control chromosomes in the GnomAD database, including 1 homozygotes. There are 23 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
GRIPAP1 (HGNC:18706): (GRIP1 associated protein 1) This gene encodes a guanine nucleotide exchange factor for the Ras family of small G proteins (RasGEF). The encoded protein interacts in a complex with glutamate receptor interacting protein 1 (GRIP1) and plays a role in the regulation of AMPA receptor function. [provided by RefSeq, Aug 2013]
Computational evidence support a benign effect (MetaRNN=0.10852456).
BP6
Variant X-48981803-C-T is Benign according to our data. Variant chrX-48981803-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 2429772.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.
Uncertain significance, criteria provided, single submitter
clinical testing
Ambry Genetics
May 28, 2023
The c.1669G>A (p.E557K) alteration is located in exon 18 (coding exon 18) of the GRIPAP1 gene. This alteration results from a G to A substitution at nucleotide position 1669, causing the glutamic acid (E) at amino acid position 557 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Seizure Benign:1
Likely benign, criteria provided, single submitter
clinical testing
Génétique des Maladies du Développement, Hospices Civils de Lyon